Kairos Pharma, LTD. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kairos Pharma, LTD. has filed 116 SEC EDGAR filings since 29 Mar 2023

SEC filing history

Showing 26-50 of 116 matching filings.

Per page
25
Current page
2
424B3 File 333-284569

424B3

Filing date
19 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-95030

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-95030

SCHEDULE 13G filing

Filing date
15 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-42275

DEF 14A

Filing date
01 May 2025
Reporting date
30 Apr 2025
Next action
Verify source filing
3

3 filing

Filing date
30 Apr 2025
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-42275

AMENDMENT TO THE FORM 10-K

Filing date
29 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
424B3 File 333-286662

424B3 filing

Filing date
25 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-286662

EFFECT filing

Filing date
24 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-286662

S-1 filing

Filing date
22 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-42275

10-K filing

Filing date
15 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .